Skip to content

Determinants of Onset and Progression of COPD in Young Adults

Early COPD: Determinants of Onset and Progression of COPD in Young Adults

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02352220
Acronym
EARLY COPD
Enrollment
310
Registered
2015-02-02
Start date
2015-01-31
Completion date
2020-12-31
Last updated
2018-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Brief summary

COPD (Chronic Obstructive Pulmonary Disease) is a Public Health problem due to its impact in the patient's quality of life, high prevalence, growing incidence and socioeconomic implication. COPD natural history and first stages determinants are unknown. Knowing them will help to understand the natural history of the disease and to design interventions that can modify the prognosis of the disease. Study objectives: (1) To characterize an early COPD population from a multidimensional point of view including demographic, social, family and clinical data, lung function, exercise capacity, image, microbiology, quality of life, exacerbations, comorbidities and blood and sputum biomarkers. (2) To compare this patients with smoking subjects, with normal lung function, matched by age, sex and site. (3) To create an early COPD cohort to be followed in the future to understand the complete natural history of the disease. Methods: Design: multicenter cross-sectional study that will allow establishing a well-characterized cohort of early COPD patients for later follow-up. Recruitment will be done in Primary Care settings. Subjects: smokers (\> 10 packs year) between 35-50 years old with a spirometry (normal or obstructive) done in the last year. Diagnosis of COPD will be based on the smoking history and a postbronchodilator test FEV1(Forced Expiratory Volume in the first second) / FVC(Forced Vital Capacity) \< 70%. Age, sex and site matched 'healthy' smoker controls will be compared with the COPD cases. Variables that will be collected in the reference hospitals are: health questionnaires, lung function test, exercise capacity, blood and sputum samples, and low dose CT-scan. Statistical analysis: early COPD patient's characteristics will be described and then, will be compared, with control subjects through a conditional multiple logistic regression analysis.

Interventions

None listed

Sponsors

Spanish Research Center for Respiratory Diseases
CollaboratorOTHER
Hospital Son Espases
CollaboratorOTHER
Hospital Clinic of Barcelona
CollaboratorOTHER
Hospital del Mar
CollaboratorOTHER
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
CollaboratorOTHER
Hospital Universitario 12 de Octubre
CollaboratorOTHER
Parc Taulí Hospital Universitari
CollaboratorOTHER
Hospitales Universitarios Virgen del Rocío
CollaboratorOTHER
Hospital Universitari de Bellvitge
CollaboratorOTHER
Hospital Arnau de Vilanova
CollaboratorOTHER
Hospital Universitario Central de Asturias
CollaboratorOTHER
University Hospital of the Nuestra Señora de Candelaria
CollaboratorOTHER
University Hospital A Coruña
CollaboratorOTHER
Barcelona Institute for Global Health
CollaboratorOTHER
Boehringer Ingelheim
CollaboratorINDUSTRY
Borja Cosio
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
35 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

\*\*Inclusion Criteria: COPD case: * Subjects between 35 and 50 years * Post-bronchodilator spirometry with FEV1/FVC \<70% * Smoker or ex-smoker with total cumulative exposure \> 10 pack-years Smoking control: * Subjects between 35 and 50 years * Post-bronchodilator spirometry with FEV1/FVC \>=70% * Smoker or ex-smoker with total cumulative exposure\> 10 pack-years *

Exclusion criteria

For cases: * Chronic inflammatory diseases including autoimmune diseases under treatment. * HIV * Active cancer * Cystic or saccular bronchiectasis * Conditions that may interfere with follow-up: frequent change of residence, psychiatric disorders, dementia… For controls: * Chronic inflammatory diseases including autoimmune diseases under treatment * HIV * Active cancer * Chronic respiratory diseases: * active tuberculosis * interstitial lung diseases * cystic or saccular bronchiectasis * ever diagnosed asthma * deficit of alpha1-antitrypsin * Conditions that may interfere with follow-up: frequent change of residence, psychiatric disorders, dementia …

Design outcomes

Primary

MeasureTime frame
Differences in lung function measures between cases and controlsAt time of visit 1 (cross-sectional)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026